首站-论文投稿智能助手
典型文献
Evaluation of the metabolism of PEP06,an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells
文献摘要:
PEP06 is a novel endostatin-Arg-Gly-Asp-Arg-Gly-Asp(RGDRGD)30-amino-acid polypeptide featuring a terminally fused RGDRGD hexapeptide at the N terminus.The active endostatin fragment of PEPO6 directly targets tumor cells and exerts an antitumoral effect.However,little is known about the kinetics and degradation products of PEP06 in vitro or in vivo.In this study,we investigated the in vitro metabolic stability of PEP06 after it was incubated with living cells obtained from animals of different species;we further identified the degradation characteristics of its cleavage products.PEP06 underwent rapid enzymatic degradation in multiple types of living cells,and the liver,kidney,and blood play important roles in the metabolism and clearance of the peptides resulting from the molecular degradation of PEP06.We identified metabolites of PEP06 using full-scan mass spectrometry(MS)and tandem MS(MS2),wherein 43 metabolites were characterized and identified as the degradation metabolites from the parent peptide,formed by successive losses of amino acids.The metabolites were C and N terminal truncated products of PEP06.The structures of 11 metabolites(M6,M7,M16,M17,M21,M25,M33,M34,M39,M40,and M42)were further confirmed by comparing the retention times of similar full MS spectrum and MS2 spectrum information with reference standards for the synthesized metabolites.We have demonstrated the metabolic stability of PEP06 in vitro and identified a series of potentially bioactive downstream metabolites of PEP06,which can support further drug research.
文献关键词:
作者姓名:
Liyun Niu;Huiyu Zhou;Yueru Lian;Ya Gao;Yulu Liu;Ruolan Gu;Zhuona Wu;Xiaoxia Zhu;Hui Gan;Zhiyun Meng;Guifang Dou
作者机构:
State Key Laboratory of Drug Metabolism and Pharmacokinetics,Department of Pharmaceutical Sciences,Beijing Institute of Radiation Medicine,Beijing,100850,China;Henan University,Kaifeng,Henan,475004,China
引用格式:
[1]Liyun Niu;Huiyu Zhou;Yueru Lian;Ya Gao;Yulu Liu;Ruolan Gu;Zhuona Wu;Xiaoxia Zhu;Hui Gan;Zhiyun Meng;Guifang Dou-.Evaluation of the metabolism of PEP06,an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells)[J].药物分析学报(英文),2022(05):766-773
A类:
PEP06,RGDRGD,hexapeptide,PEPO6,antitumoral,M34
B类:
Evaluation,metabolism,endostatin,amino,polypeptide,promising,novel,drug,targeting,cells,Arg,Gly,Asp,featuring,terminally,fused,terminus,fragment,directly,targets,exerts,effect,However,little,known,about,kinetics,degradation,products,vitro,vivo,In,this,study,investigated,metabolic,stability,after,was,incubated,living,obtained,from,animals,different,species,further,identified,characteristics,its,cleavage,underwent,rapid,enzymatic,multiple,types,liver,kidney,blood,play,important,roles,clearance,peptides,resulting,molecular,We,metabolites,using,full,scan,mass,spectrometry,tandem,MS2,wherein,were,characterized,parent,formed,by,successive,losses,acids,truncated,structures,M6,M7,M16,M17,M21,M25,M33,M39,M40,M42,confirmed,comparing,retention,times,similar,spectrum,information,reference,standards,synthesized,have,demonstrated,series,potentially,bioactive,downstream,which,support,research
AB值:
0.502559
相似文献
Pharmacodynamic,pharmacokinetic,and phase 1a study of bisthianostat,a novel histone deacetylase inhibitor,for the treatment of relapsed or refractory multiple myeloma
Yu-bo Zhou;Yang-ming Zhang;Hong-hui Huang;Li-jing Shen;Xiao-feng Han;Xiao-bei Hu;Song-da Yu;An-hui Gao;Li Sheng;Ming-bo Su;Xiao-li Wei;Yue Zhang;Yi-fan Zhang;Zhi-wei Gao;Xiao-yan Chen;Fa-jun Nan;Jia Li;Jian Hou-National Center for New Drug Screening,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Yantai Key Laboratory of Nanomedicine&Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China;Department of Hematology,Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200127,China;Shanghai Center for Drug Metabolism and Pharmacokinetics Research,Shanghai 201203,China
Intrarenal 1-methoxypyrene,an aryl hydrocarbon receptor agonist,mediates progressive tubulointerstitial fibrosis in mice
Gang Cao;Hua Miao;Yan-ni Wang;Dan-qian Chen;Xia-qing Wu;Lin Chen;Yan Guo;Liang Zou;Nosratola D.Vaziri;Ping Li;Ying-yong Zhao-School of Pharmacy,Zhejiang Chinese Medical University,No.548 Binwen Road,Hangzhou 310053,China;Faculty of Life Science&Medicine,Northwest University,No.229 Taibai North Road,Xi'an 710069,China;Beijing Key Lab for Immune-Mediated Inflammatory Diseases,Institute of Clinical Medical Science,Department of Nephrology,China-Japan Friendship Hospital,No.2 Yinghua East Road,Beijing 100029,China;Department of Internal Medicine,University of New Mexico,1700 Lomas Blvd NE,Albuquerque,NM 87131,USA;School of Food and Bioengineering,Chengdu University,No.2025 Chengluo Avenue,Chengdu 610106,China;Division of Nephrology and Hypertension,School of Medicine,University of California Irvine,1001 Health Sciences Rd,Irvine,CA 92897,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。